» Articles » PMID: 36670946

Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies

Overview
Date 2023 Jan 21
PMID 36670946
Authors
Affiliations
Soon will be listed here.
Abstract

Reprogrammed metabolism is regarded as a hallmark of cancer and offers a selective advantage to tumor cells during carcinogenesis. The redox equilibrium is necessary for growth, spread and the antioxidant pathways are boosted following Reactive Oxygen Species (ROS) production to prevent cell damage in tumor cells. Human herpesvirus 8 (HHV-8), the etiologic agent of Kaposi sarcoma KS and primary effusion lymphoma (PEL), is an oncogenic virus that disrupts cell survival-related molecular signaling pathways leading to immune host evasion, cells growths, angiogenesis and inflammatory tumor-environment. We recently reported that primaquine diphosphate causes cell death by apoptosis in HHV-8 infected PEL cell lines in vivo and exhibits therapeutic anti-tumor activity in mice models and advanced KS. Our findings also suggest that the primaquine-induced apoptosis in PEL cells is mostly influenced by ROS production and targeting the redox balance could be a new approach to treat HHV-8 related diseases. In this review, we summarized the knowledge about the influence of ROS in cancer development; more specifically, the proof of evidence from our work and from the literature that redox pathways are important for the development of HHV-8 pathologies.

Citing Articles

Superoxide dismutase alterations in COVID-19: implications for disease severity and mortality prediction in the context of omicron variant infection.

Chu J, Hua L, Liu X, Xiong H, Jiang F, Zhou W Front Immunol. 2024; 15:1362102.

PMID: 38464514 PMC: 10921560. DOI: 10.3389/fimmu.2024.1362102.


Theoretical investigation on a simple turn on fluorescent probe for detection of biothiols based on coumarin unit.

Ma T, Huang H, Liu Y, Peng Y Front Chem. 2023; 11:1290745.

PMID: 38025079 PMC: 10663294. DOI: 10.3389/fchem.2023.1290745.


Comparative polar and lipid plasma metabolomics differentiate KSHV infection and disease states.

Privatt S, Braga C, Johnson A, Lidenge S, Berry L, Ngowi J Cancer Metab. 2023; 11(1):13.

PMID: 37653396 PMC: 10470137. DOI: 10.1186/s40170-023-00316-0.

References
1.
Patra K, Wang Q, Bhaskar P, Miller L, Wang Z, Wheaton W . Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell. 2013; 24(2):213-228. PMC: 3753022. DOI: 10.1016/j.ccr.2013.06.014. View

2.
Brand M . The sites and topology of mitochondrial superoxide production. Exp Gerontol. 2010; 45(7-8):466-72. PMC: 2879443. DOI: 10.1016/j.exger.2010.01.003. View

3.
Cox A, Winterbourn C, Hampton M . Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling. Biochem J. 2009; 425(2):313-25. DOI: 10.1042/BJ20091541. View

4.
Simonart T, Boelaert J, van Vooren J . Enhancement of classic Kaposi's sarcoma growth after intralesional injections of desferrioxamine. Dermatology. 2002; 204(4):290-2. DOI: 10.1159/000063361. View

5.
Li X, Feng J, Sun R . Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells. J Virol. 2010; 85(2):715-24. PMC: 3020037. DOI: 10.1128/JVI.01742-10. View